GALMED PHARMACEUTICALS LTD. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
GALMED PHARMACEUTICALS LTD. (GLMD) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -$8.98 million for the 12-month period ending 2020-12-31, per its 20-F filed 2021-03-18.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2021-03-18
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|
| 2020-12-31 | -$8.98M 20-F · filed 2021-03-18 | |
| 2020-06-30 | -$10.38M 6-K · filed 2020-08-06 | |
| 2019-12-31 | -$8.12M 20-F · filed 2021-03-18 | |
| 2019-06-30 | $1.62M 6-K · filed 2020-08-06 | |
| 2018-12-31 | $11.14M 20-F · filed 2021-03-18 | |
| 2017-12-31 | $9.92M 20-F · filed 2020-03-12 |